181 related articles for article (PubMed ID: 8082090)
1. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence.
Nakamori S; Watanabe H; Kameyama M; Imaoka S; Furukawa H; Ishikawa O; Sasaki Y; Kabuto T; Raz A
Cancer; 1994 Oct; 74(7):1855-62. PubMed ID: 8082090
[TBL] [Abstract][Full Text] [Related]
2. Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma.
Maruyama K; Watanabe H; Shiozaki H; Takayama T; Gofuku J; Yano H; Inoue M; Tamura S; Raz A; Monden M
Int J Cancer; 1995 Oct; 64(5):316-21. PubMed ID: 7591303
[TBL] [Abstract][Full Text] [Related]
3. Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.
Hirono Y; Fushida S; Yonemura Y; Yamamoto H; Watanabe H; Raz A
Br J Cancer; 1996 Dec; 74(12):2003-7. PubMed ID: 8980404
[TBL] [Abstract][Full Text] [Related]
4. Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.
Otto T; Birchmeier W; Schmidt U; Hinke A; Schipper J; Rübben H; Raz A
Cancer Res; 1994 Jun; 54(12):3120-3. PubMed ID: 8205527
[TBL] [Abstract][Full Text] [Related]
5. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
Tanizaki Y; Sato Y; Oka H; Utsuki S; Kondo K; Miyajima Y; Nagashio R; Fujii K
Pathol Int; 2006 Sep; 56(9):510-5. PubMed ID: 16930331
[TBL] [Abstract][Full Text] [Related]
6. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
[TBL] [Abstract][Full Text] [Related]
7. Autocrine motility factor receptor expression associates with tumor progression in thymoma.
Ohta Y; Minato H; Tanaka Y; Go T; Oda M; Watanabe Y
Int J Oncol; 2000 Aug; 17(2):259-64. PubMed ID: 10891533
[TBL] [Abstract][Full Text] [Related]
8. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
Silletti S; Yao JP; Pienta KJ; Raz A
Int J Cancer; 1995 Sep; 63(1):100-5. PubMed ID: 7558435
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.
Huang Z; Zhang N; Zha L; Mao HC; Chen X; Xiang JF; Zhang H; Wang ZW
Asian Pac J Cancer Prev; 2014; 15(2):989-97. PubMed ID: 24568530
[TBL] [Abstract][Full Text] [Related]
10. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
12. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
Jiang WG; Raz A; Douglas-Jones A; Mansel RE
J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.
Akagi Y; Adachi Y; Ohchi T; Kinugasa T; Shirouzu K
Anticancer Res; 2013 Jul; 33(7):2965-70. PubMed ID: 23780987
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of perineural invasion in stages II and III colorectal cancer.
Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
[TBL] [Abstract][Full Text] [Related]
15. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
Nakazawa T; Goi T; Hirono Y; Yamaguchi A
Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
[TBL] [Abstract][Full Text] [Related]
16. AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78.
Haga A; Komazaki S; Funasaka T; Hashimoto K; Yokoyama Y; Watanabe H; Raz A; Nagase H
Leuk Lymphoma; 2006 Oct; 47(10):2234-43. PubMed ID: 17071500
[TBL] [Abstract][Full Text] [Related]
17. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
Endo K; Shirai A; Furukawa M; Yoshizaki T
Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
[TBL] [Abstract][Full Text] [Related]
19. Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer.
Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K; Raz A
Int J Cancer; 2001 Nov; 95(6):384-7. PubMed ID: 11668522
[TBL] [Abstract][Full Text] [Related]
20. [The role of autocrine motility factor receptor in metastasis].
Watanabe H; Chigira M; Raz A
Gan To Kagaku Ryoho; 1993 Feb; 20(3):405-9. PubMed ID: 8382466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
